Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Taiwan
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sinphar Pharmaceutical Co Ltd

+ Add to Watchlist

1734:TT

39.80 TWD 0.20 0.50%

As of 02:41:11 ET on 03/27/2015.

Snapshot for Sinphar Pharmaceutical Co Ltd (1734)

Open: 40.35 Day's Range: 39.70 - 40.35 Volume: 333,793
Previous Close: 40.00 52wk Range: 38.29 - 53.98 1-Yr Rtn: -12.44%

Stock Chart for 1734

No chart data available.
  • 1734:TT 39.80
  • 1D
  • 1M
  • 1Y
40.00
Interactive 1734 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 1734

Current P/E Ratio (ttm) 45.3897
Estimated P/E(12/2014) 29.7681
Relative P/E vs. TWSE 2.9851
Earnings Per Share (TWD) (ttm) 0.8769
Est. EPS (TWD) (12/2014) 1.3370
Est. PEG Ratio -
Market Cap (M TWD) 6,418.59
Shares Outstanding (M) 161.27
30 Day Average Volume 381,065
Price/Book (mrq) 2.1410
Price/Sale (ttm) 2.4185
Dividend Indicated Gross Yield 2.01%
Cash Dividend (TWD) 0.8000
Dividend Ex-Date
5 Year Dividend Growth 18.79%
Next Earnings Announcement 04/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 1734

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 1734

Sinphar Pharmaceutical Co., Ltd. manufactures and markets medical drugs, functional food products, medical devices, and cosmetic products.

Li Chih-WenChairmanPai Yu-LangPresident:Taiwan Area
Yu Neng-YingPresident:China Affairs OfficeLi I-TaChief Research Officer
More Company Profile & Key Executives for 1734

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil